|
GCC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.200000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.154410E-01 |
| Normal-vs-Stage2 |
2.755400E-03 |
| Normal-vs-Stage3 |
2.93020000041722E-07 |
| Normal-vs-Stage4 |
1.538360E-03 |
| Stage1-vs-Stage2 |
3.884500E-02 |
| Stage1-vs-Stage3 |
4.22700000000109E-05 |
| Stage1-vs-Stage4 |
1.910490E-02 |
| Stage2-vs-Stage3 |
3.506400E-01 |
| Stage2-vs-Stage4 |
9.995600E-01 |
| Stage3-vs-Stage4 |
3.174000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.157200E-04 |
| Normal-vs-AfricanAmerican |
3.885600E-02 |
| Normal-vs-Asian |
7.328400E-02 |
| Caucasian-vs-AfricanAmerican |
8.809200E-01 |
| Caucasian-vs-Asian |
7.516000E-01 |
| AfricanAmerican-vs-Asian |
7.197400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.177470E-04 |
| Normal-vs-Female |
1.098180E-02 |
| Male-vs-Female |
2.432800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.425400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.414300E-04 |
| Normal-vs-Age(61-80Yrs) |
4.141400E-03 |
| Normal-vs-Age(81-100Yrs) |
3.493900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.671200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.798200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.645400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.606000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.011400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.106600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.858200E-01 |
| Normal-vs-Grade 2 |
5.334200E-02 |
| Normal-vs-Grade 3 |
3.08579999996894E-06 |
| Normal-vs-Grade 4 |
6.434700E-04 |
| Grade 1-vs-Grade 2 |
1.101400E-01 |
| Grade 1-vs-Grade 3 |
9.419600E-03 |
| Grade 1-vs-Grade 4 |
2.425500E-02 |
| Grade 2-vs-Grade 3 |
2.078200E-03 |
| Grade 2-vs-Grade 4 |
2.138300E-02 |
| Grade 3-vs-Grade 4 |
6.940400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.350300E-02 |
| Normal-vs-ccB subtype |
9.88180000000005E-05 |
| ccA subtype-vs-ccB subtype |
9.362200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.236170E-04 |
| Normal-vs-N1 |
6.921200E-01 |
| N0-vs-N1 |
5.653600E-01 |
|
|
